Related Experiment Video
Updated: Aug 6, 2026

05:47
Use of a Rat Model to Study Ventral Abdominal Hernia Repair
Published on: October 2, 2017
Open Rives-Stoppa ventral hernia repair made simple and successful but not for everyone
L Heartsill1, M L Richards, N Arfai
1Department of Surgery, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX, 78229-3900, USA.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|February 22, 2005
Summary
The Rives-Stoppa (RS) repair for ventral incisional hernias (VIHR) using intraperitoneal mesh is effective and technically simpler. However, wound infections and pulmonary disease significantly increase hernia recurrence rates.
Area of Science:
- Abdominal Surgery
- Hernia Repair
- Surgical Innovation
Background:
- The Rives-Stoppa (RS) repair for ventral incisional hernias (VIHR) is a complex procedure.
- Traditional RS repair involves retromuscular mesh placement and primary anterior fascia closure, with recurrence rates between 0-8%.
Purpose of the Study:
- To evaluate the success of an open RS-VIHR using intraperitoneal mesh placement.
- To identify factors associated with hernia recurrence after this modified RS repair.
Main Methods:
- An open Rives-Stoppa ventral incisional hernia repair (RS-VIHR) with intraperitoneal mesh was performed on 81 patients.
- Patients were evaluated for hernia recurrence and potential contributing factors.
Main Results:
- The overall recurrence rate was 15% (12/81), with 10% recurrence excluding cases related to mesh infection or laparotomy.
- No correlation was found between recurrence and patient demographics, hernia characteristics, or surgical factors (p>0.05).
- Wound infection/abscess formation (60% vs. 8%) and pulmonary disease (50% vs. 12%) were significantly associated with higher recurrence rates (p<0.001 and p=0.01, respectively).
Conclusions:
- RS-VIHR with intraperitoneal mesh offers a successful and less technically demanding alternative to traditional methods.
- Prompt identification and treatment of infections are crucial to prevent abscesses and recurrence.
- Elective RS-VIHR is not recommended for patients with chronic pulmonary disease due to high recurrence rates.

